Yahoo India Web Search

Search results

    • Eisai and Bristol Myers cancel cancer ADC deal

      Eisai and Bristol Myers cancel cancer ADC deal

      BioPharma Dive· 3 days ago

      The Japan-based drugmaker said its U.S. partner’s “portfolio prioritization efforts” led to the termination. It will refund part of an upfront payment.

    • 5 FDA decisions to watch in the third quarter

      5 FDA decisions to watch in the third quarter

      BioPharma Dive· 1 day ago

      Multibillion-dollar buyouts from Bristol Myers Squibb and Gilead could yield new drugs for brain and liver diseases, while a new cell therapy may reach...